South San Francisco, California, United States
Contact Info
5K followers
500+ connections
South San Francisco, California, United States
Contact Info
5K followers
500+ connections
About
David Lustig, Ph.D. is a life science business development professional with over 20…
Articles by David
-
New FDA Draft Guidances as of April 26, 2024: Oncology Trials and More
New FDA Draft Guidances as of April 26, 2024: Oncology Trials and More
By David Lustig
-
Dr. Kary Mullis Nobel Laureate, PCR Inventor, Noted Contrarian Has Died at 74
Dr. Kary Mullis Nobel Laureate, PCR Inventor, Noted Contrarian Has Died at 74
By David Lustig
Contributions
Activity
-
Register to Episode 1 of our new webinar series on Oligonucleotides Therapeutics: Discovery to Development! Our first speaker is Prof. Carlo Rinaldi…
Register to Episode 1 of our new webinar series on Oligonucleotides Therapeutics: Discovery to Development! Our first speaker is Prof. Carlo Rinaldi…
Liked by David Lustig
-
Four of our 6 avacopan clinpharm manuscripts got published recently, including two published last Fri back to back. Two more to go (ADME and…
Four of our 6 avacopan clinpharm manuscripts got published recently, including two published last Fri back to back. Two more to go (ADME and…
Liked by David Lustig
Experience & Education
Publications
Recommendations received
-
LinkedIn User
10 people have recommended David
Join now to viewMore activity by David
-
A list of tumor biomarkers: https://lnkd.in/geUPFDeh
A list of tumor biomarkers: https://lnkd.in/geUPFDeh
Liked by David Lustig
-
Exciting news! Our 1993 paper, "From ions in solution to ions in the gas phase - the mechanism of electrospray mass spectrometry" (co-authored with…
Exciting news! Our 1993 paper, "From ions in solution to ions in the gas phase - the mechanism of electrospray mass spectrometry" (co-authored with…
Liked by David Lustig
-
Evotec synthesizes oligos for discovery up to enough material for a tox study.
Evotec synthesizes oligos for discovery up to enough material for a tox study.
Shared by David Lustig
-
A new exciting webinar series hosted by Evotec! We will focus on #oligonucleotides discovery and development. We start with Episode 1 on July 23rd…
A new exciting webinar series hosted by Evotec! We will focus on #oligonucleotides discovery and development. We start with Episode 1 on July 23rd…
Liked by David Lustig
-
Great opportunity to join a great team and great leader!
Great opportunity to join a great team and great leader!
Liked by David Lustig
-
Evotec SE announced that its biologics segment, Just - Evotec Biologics, has expanded its strategic partnership with Sandoz. Just – Evotec Biologics…
Evotec SE announced that its biologics segment, Just - Evotec Biologics, has expanded its strategic partnership with Sandoz. Just – Evotec Biologics…
Liked by David Lustig
-
Very interesting paper on a molecular glue degrader targeting WIZ. A path to potentially curing sickle cell disease. Many congrats to the authors…
Very interesting paper on a molecular glue degrader targeting WIZ. A path to potentially curing sickle cell disease. Many congrats to the authors…
Liked by David Lustig
-
I am excited to introduce Embold Therapeutics as the next chapter in my career! At Embold we are addressing metabolic insufficiencies that impact…
I am excited to introduce Embold Therapeutics as the next chapter in my career! At Embold we are addressing metabolic insufficiencies that impact…
Liked by David Lustig
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named David Lustig in United States
39 others named David Lustig in United States are on LinkedIn
See others named David Lustig